| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Nasdaq Copenhagen A/S: Bavarian Nordic A/S - admittance to trading and official listing of new shares due to employees' exercise of warrants | 141 | GlobeNewswire | The share capital of Bavarian Nordic A/S will be increased on Nasdaq
Copenhagen. The admittance of trading and official listing of new shares will
take effect as per 23 May 2024 in the ISIN below.
ISIN:... ► Artikel lesen | |
| Mi | Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise | 2 | GlobeNewswire (USA) | ||
| 21.05. | Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program | 4 | GlobeNewswire (USA) | ||
| 21.05. | Bavarian Nordic A/S: EVP and Chief Medical Officer Laurence de Moerlooze Will Be Leaving Bavarian Nordic | 111 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, May 21, 2024 - Bavarian Nordic A/S (OMX: BAVA) today announced that Laurence de Moerlooze will leave her position as Executive Vice President and Chief Medical Officer in the... ► Artikel lesen | |
| 11.05. | Earnings call: Bavarian Nordic sees demand rise for travel vaccines | 10 | Investing.com | ||
| 08.05. | Bavarian Nordic A/S reports Q1 results | 14 | Seeking Alpha | ||
| 08.05. | Bavarian Nordic A/S: Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations | 8 | GlobeNewswire (USA) | ||
| 08.05. | Bavarian Nordic A/S: Bavarian Nordic Announces Interim Results for the First Three Months of 2024 | 319 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, May 8, 2024 - Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2024.
Revenue for the first three... ► Artikel lesen | |
| 07.05. | Bavarian Nordic A/S: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such | 4 | GlobeNewswire (USA) | ||
| 29.04. | Bavarian Nordic A/S: Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve | 391 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, April 29, 2024 - Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued at EUR 65 million to supply its MVA-BN® smallpox vaccine to the strategic reserve... ► Artikel lesen | |
| 29.04. | Bavarian Nordic A/S: Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate | 455 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, April 29, 2024 - Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a Biologics... ► Artikel lesen | |
| 22.04. | Bavarian Nordic A/S: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such | 11 | GlobeNewswire (USA) | ||
| 16.04. | Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S | 90 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, April 16, 2024 - Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results: The Annual Report for 2023 was adopted. The Board of Directors'... ► Artikel lesen | |
| 03.04. | Bavarian Nordic announces commercial availability of mpox vaccine in US | 381 | Pharmaceutical Business Review | ||
| 02.04. | Bavarian Nordic expands access to mpox vaccine in US | 73 | Pharmaceutical Technology | ||
| 02.04. | Bavarian Nordic: Wichtige Mitteilung - so reagiert die Aktie | 405 | finanztreff.de | Bavarian Nordic hat am Dienstagmorgen die Markteinführung von JYNNEOS® in den Vereinigten Staaten angekündigt, einem Meilenstein, der die Präsenz des Unternehmens im Kampf gegen Mpox unterstreicht.... ► Artikel lesen | |
| 02.04. | Bavarian Nordic A/S: Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S. | 201 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, April 2, 2024 - Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the U.S., marking a significant... ► Artikel lesen | |
| 21.03. | Bavarian Nordic A/S - Notice Convening Annual General Meeting | 4 | GlobeNewswire (USA) | ||
| 13.03. | Bavarian Nordic A/S: Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland | 323 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, March 13, 2024 - Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved JYNNEOS® (MVA-BN) for active immunization... ► Artikel lesen | |
| 12.03. | Bavarian Nordic A/S: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such | 248 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, March 12, 2024 - Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company's shares/related securities by persons holding managerial... ► Artikel lesen |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NEL | 7.068 |
| GAMESTOP | 4.462 |
| NVIDIA | 4.438 |
| EVOTEC | 3.999 |
| TUI | 2.832 |
| BAYER | 2.174 |
| PLUG POWER | 1.844 |
| BIONTECH | 1.516 |
| RHEINMETALL | 1.515 |
| VOLKSWAGEN | 1.349 |
| SUPER MICRO COMPUTER | 1.271 |
| DEUTSCHE LUFTHANSA | 1.223 |
| AIXTRON SE | 1.169 |
| SIEMENS ENERGY | 1.130 |
| BYD | 1.024 |
| MERCEDES-BENZ | 994 |
| RWE | 938 |
| COMMERZBANK | 936 |
| HEIDELBERGER DRUCK | 869 |
| TESLA | 854 |
| DEUTSCHE BANK | 829 |
| RENK GROUP | 820 |
| JINKOSOLAR | 772 |
| NORDEX | 745 |
| BASF | 740 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
